SRGAP2C and cancer: The promoter-region DMR on SRGAP2C showed significant hypermethylation between all three groups (see Figure 1c), with the lowest at 14% proportional change between the obese and non-obese cancer group, and it revealed a marginal interaction with age in the GR model.